Cargando…
Natural Formulations: Novel Viewpoint for Scleroderma Adjunct Treatment
BACKGROUND: Scleroderma is a complex disease involving autoimmune, vascular, and connective tissues, with unknown etiology that can progress through any organ systems. OBJECTIVE: Yet, no cure is available; the thorough treatment of scleroderma and current treatments are based on controlling inflamma...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253639/ https://www.ncbi.nlm.nih.gov/pubmed/34258301 http://dx.doi.org/10.1155/2021/9920416 |
_version_ | 1783717555113820160 |
---|---|
author | Assar, Shirin Khazaei, Hosna Naseri, Maryam El-Senduny, Fardous Momtaz, Saeideh Farzaei, Mohammad Hosein Echeverría, Javier |
author_facet | Assar, Shirin Khazaei, Hosna Naseri, Maryam El-Senduny, Fardous Momtaz, Saeideh Farzaei, Mohammad Hosein Echeverría, Javier |
author_sort | Assar, Shirin |
collection | PubMed |
description | BACKGROUND: Scleroderma is a complex disease involving autoimmune, vascular, and connective tissues, with unknown etiology that can progress through any organ systems. OBJECTIVE: Yet, no cure is available; the thorough treatment of scleroderma and current treatments are based on controlling inflammation. Nowadays, medicinal plants/natural-based formulations are emerging as important regulators of many diseases, including autoimmune diseases. Here, we provided an overview of scleroderma, also focused on recent studies on medicinal plants/natural-based formulations that are beneficial in scleroderma treatment/prevention. METHODS: This study is the result of a search in PubMed, Scopus, and Cochrane Library with “scleroderma”, “systemic sclerosis”, “plant”, “herb”, and “phytochemical” keywords. Finally, 22 articles were selected from a total of 1513 results entered in this study. RESULTS: Natural products can modulate the inflammatory and/or oxidative mediators, regulate the production or function of the immune cells, and control the collagen synthesis, thereby attenuating the experimental and clinical manifestation of the disease. CONCLUSION: Natural compounds can be considered an adjunct treatment for scleroderma to improve the quality of life of patients suffering from this disease. |
format | Online Article Text |
id | pubmed-8253639 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-82536392021-07-12 Natural Formulations: Novel Viewpoint for Scleroderma Adjunct Treatment Assar, Shirin Khazaei, Hosna Naseri, Maryam El-Senduny, Fardous Momtaz, Saeideh Farzaei, Mohammad Hosein Echeverría, Javier J Immunol Res Review Article BACKGROUND: Scleroderma is a complex disease involving autoimmune, vascular, and connective tissues, with unknown etiology that can progress through any organ systems. OBJECTIVE: Yet, no cure is available; the thorough treatment of scleroderma and current treatments are based on controlling inflammation. Nowadays, medicinal plants/natural-based formulations are emerging as important regulators of many diseases, including autoimmune diseases. Here, we provided an overview of scleroderma, also focused on recent studies on medicinal plants/natural-based formulations that are beneficial in scleroderma treatment/prevention. METHODS: This study is the result of a search in PubMed, Scopus, and Cochrane Library with “scleroderma”, “systemic sclerosis”, “plant”, “herb”, and “phytochemical” keywords. Finally, 22 articles were selected from a total of 1513 results entered in this study. RESULTS: Natural products can modulate the inflammatory and/or oxidative mediators, regulate the production or function of the immune cells, and control the collagen synthesis, thereby attenuating the experimental and clinical manifestation of the disease. CONCLUSION: Natural compounds can be considered an adjunct treatment for scleroderma to improve the quality of life of patients suffering from this disease. Hindawi 2021-06-24 /pmc/articles/PMC8253639/ /pubmed/34258301 http://dx.doi.org/10.1155/2021/9920416 Text en Copyright © 2021 Shirin Assar et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Assar, Shirin Khazaei, Hosna Naseri, Maryam El-Senduny, Fardous Momtaz, Saeideh Farzaei, Mohammad Hosein Echeverría, Javier Natural Formulations: Novel Viewpoint for Scleroderma Adjunct Treatment |
title | Natural Formulations: Novel Viewpoint for Scleroderma Adjunct Treatment |
title_full | Natural Formulations: Novel Viewpoint for Scleroderma Adjunct Treatment |
title_fullStr | Natural Formulations: Novel Viewpoint for Scleroderma Adjunct Treatment |
title_full_unstemmed | Natural Formulations: Novel Viewpoint for Scleroderma Adjunct Treatment |
title_short | Natural Formulations: Novel Viewpoint for Scleroderma Adjunct Treatment |
title_sort | natural formulations: novel viewpoint for scleroderma adjunct treatment |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253639/ https://www.ncbi.nlm.nih.gov/pubmed/34258301 http://dx.doi.org/10.1155/2021/9920416 |
work_keys_str_mv | AT assarshirin naturalformulationsnovelviewpointforsclerodermaadjuncttreatment AT khazaeihosna naturalformulationsnovelviewpointforsclerodermaadjuncttreatment AT naserimaryam naturalformulationsnovelviewpointforsclerodermaadjuncttreatment AT elsendunyfardous naturalformulationsnovelviewpointforsclerodermaadjuncttreatment AT momtazsaeideh naturalformulationsnovelviewpointforsclerodermaadjuncttreatment AT farzaeimohammadhosein naturalformulationsnovelviewpointforsclerodermaadjuncttreatment AT echeverriajavier naturalformulationsnovelviewpointforsclerodermaadjuncttreatment |